Niagen Bioscience (NAGE) Deferred Taxes (2011 - 2026)

Niagen Bioscience (NAGE) posted quarterly Deferred Taxes of $41000.0 for Q1 2026, up 356.25% quarter-over-quarter from -$16000.0 in Q4 2018.

Niagen Bioscience (NAGE) Deferred Taxes (2011 - 2026) Analysis & Trends

Niagen Bioscience (NAGE) has reported Deferred Taxes for 7 consecutive years, with $41000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Deferred Taxes changed N/A year-over-year to $41000.0; the TTM figure through Mar 2026 stood at $41000.0 (changed N/A YoY), while the FY2018 annual figure was $2000.0, down 98.89% from the prior year.
  • Deferred Taxes climbed to $41000.0 in Q1 2026 per NAGE's latest filing, from -$16000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $41000.0 in Q1 2026 and bottomed at $41000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -69.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 194.40 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -137,876.64
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.66 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Niagen Bioscience 238.30 Mn 171.56 Mn 19.31 Mn 1,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 41,000.00
Dec 31, 2018 -16,000.00
Sep 30, 2018 -8,000.00
Jun 30, 2018 76,000.00
Mar 31, 2018 -50,000.00
Dec 30, 2017 -8,000.00
Sep 30, 2017 168,000.00
Jul 1, 2017 -20,000.00
Apr 1, 2017 40,000.00
Dec 31, 2016 321,037.00
Oct 1, 2016 75,977.00
Jul 2, 2016 125,514.00
Apr 2, 2016 -18,857.00
Jan 2, 2016 -32,713.00
Mar 30, 2013 -15,621.00
Dec 29, 2012 -14,849.00
Sep 29, 2012 -14,849.00
Jun 30, 2012 -14,223.00
Mar 31, 2012 -15,811.00